Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-27

Clinical Trial Update: Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating varenicline augmentation to patch-based smoking cessation in individuals who are heavy drinkers; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Patch (nicotine replacement therapy patch) (nicotine patch)
  • Varenicline (varenicline)

Snippet

Sponsor: University of Chicago | Conditions: Smoking Cessation, Alcohol Drinking | Phase 4 | Status: COMPLETED | Results posted: 2021-09-27